Neptinib
Neptinib (NEP010) is an orally active derivative of Afatinib (HY-10261) that has stronger antitumor activity than Afatinib (HY-10261) by improving pharmacokinetics. Neptinib has a significant inhibitory effect on tumor growth in mouse non-small cell lung cancer models with different EGFR mutations. Neptinib has a certain inhibitory effect on the EGFR kinase family, with IC50 values ??of 0.24 nM, 7.25 nM, 0.46 nM and 1.79 nM for EGFRwt, EGFRL858R/T790M, EGFRL858R and EGFRT790M, respectively.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 2085843-51-0
- Fòrmula: C22H23ClFN5O2
- Peso molecular:443.90
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas EGFR
More
Actividad biológica
|
EGFR (WT) 0.24 nM (IC50) |
EGFRL858R/T790M 7.25 nM (IC50) |
EGFRL858R 0.46 nM (IC50) |
EGFRT790M 1.79 nM (IC50) |
Chemical Information
-
No. CAS 2085843-51-0
-
Peso molecular 443.90
-
Fòrmula C22H23ClFN5O2
-
SMILES
FC(C=C1)=C(Cl)C=C1NC2=NC=NC3=C2C=C(NC(/C=C/CN(C)C)=O)C(OCC)=C3
-
Synonyms
NEP010
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)